Megan Fuller

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Genome Wide Association Study

Multiple Myeloma

Acute Lymphoblastic Leukemia

Long Noncoding Rna

Top Venues

The Journal of experimental medicine

Nature cell biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Aparna Gopal, Rawa Ibrahim, Megan Fuller, Patricia Umlandt, Jeremy D K Parker, Jessica Tran, Linda Chang, Joanna Wegrzyn-Woltosz, Jeffrey Lam, Jenny Li, Melody Lu, Aly Karsan
TIRAP drives myelosuppression through an Ifnγ-Hmgb1 axis that disrupts the endothelial niche in mice. The Journal of experimental medicine 219 (3) (2022)
Sergio Martinez-Høyer, Yu Deng, Jeremy D K Parker, Jihong Jiang, Angela Mo, T Roderick Docking, Nadia Gharaee, Jenny Li, Patricia Umlandt, Megan Fuller, Martin Jädersten, Austin Kulasekararaj, Luca Malcovati, Alan F List, Eva Hellström-Lindberg, Uwe Platzbecker, Aly Karsan
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome. Nature cell biology 22 (5) (2020)
Katey S S Enfield, Erin A Marshall, Christine Anderson, Kevin W Ng, Sara Rahmati, Zhaolin Xu, Megan Fuller, Katy Milne, Daniel Lu, Rocky Shi, David A Rowbotham, Daiana D Becker-Santos, Fraser D Johnson, John C English, Calum E MacAulay, Stephen Lam, William W Lockwood, Raj Chari, Aly Karsan, Igor Jurisica, Wan L Lam
Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma. Nature communications 10 (1) (2019)